In VivoEvaluation of pH-Sensitive Polymer-Based Immunoliposomes Targeting the CD33 Antigen
Authors:
- 17 May 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (4) , 1098-1107
Abstract
The purpose of this study was to evaluate in vivo a targeted pH-sensitive liposomal formulation tailored to promote the efficient intracellular delivery of 1-β-d-arabinofuranosylcytosine (ara-C) to human myeloid leukemia cells. Specifically, pH-sensitive immunoliposomes were obtained by anchoring a copolymer of dioctadecyl, N-isopropylacrylamide and methacrylic acid in bilayers of PEGylated liposomes (LP) and by coupling the whole anti-CD33 monoclonal antibody (mAb) or its Fab′ fragments. Their pharmacokinetic and biodistribution profiles were assessed in Balb/c and leukemic HL60-bearing immunodepressed (SCID) mice. In naive mice, nontargeted and pH-sensitive Fab′-LP had longer circulation times than LP with whole mAb. In SCID/HL60 (CD33+) mice, the pharmacokinetic and biodistribution profiles of LP and encapsulated ara-C were comparable between nontargeted and pH-sensitive Fab′-LP. In leukemic mice, only pH-insensitive, ara-C-loaded Fab′ induced prolonged survival times. The apparent absence of pH-sensitive Fab′-LP effect could be related to lower exposure to ara-C in SCID mice.Keywords
This publication has 38 references indexed in Scilit:
- pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cellsInternational Journal of Pharmaceutics, 2009
- Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab′ fragments and single chain FvJournal of Controlled Release, 2008
- A simply and sensitive fluorometric method for determination of gentamicin in liposomal suspensionsInternational Journal of Pharmaceutics, 2006
- Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrenceCancer, 2005
- On the Characterization of pH-sensitive Liposome/Polymer ComplexesBiomacromolecules, 2002
- Clinical Pharmacokinetics of Cytarabine FormulationsClinical Pharmacokinetics, 2002
- Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab′ fragmentsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Clearance properties of liposomes involving conjugated proteins for targetingAdvanced Drug Delivery Reviews, 1998
- Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Mechanisms of delivery of liposome-encapsulated cytosine arabinoside to CV-1 cells in vitro. Fluorescence-microscopic and cytotoxicity studiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990